Global Blood Therapeutics Inc GBT shares are soaring in Wednesday's after-hours session following a report suggesting the company is attracting takeover interest.
According to a Bloomberg report, citing people familiar with the matter, some large pharmaceutical companies are looking into a potential deal. Global Blood Therapeutics is reportedly working with advisors to evaluate potential takeover offers.
Global Blood Therapeutics is a biopharmaceutical company focused on discovering, developing, and delivering life-changing treatments that provide hope to underserved patient communities, starting with sickle cell disease.
The company is set to report its second-quarter financial results after the market close on Aug. 8.
See Also: Mercadolibre Shares Soar On Solid Q2 Revenue Growth, Margin Expansion
GBT Price Action: Global Blood Therapeutics is making new 52-week highs in Wednesday's after-hours session.
The stock was up 29.7% in after-hours at $44 at press time, according to Benzinga Pro.
Photo: PublicDomainPictures from Pixabay.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
